SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Bambusa Therapeutics expects IPO price of $15–$17 per share

Valid market news retained in the public archive without immediate LiveCast distribution.

Related stories